Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Times Interest Earned (2016 - 2025)

Altimmune (ALT) has disclosed Times Interest Earned for 16 consecutive years, with -$42.14 as the latest value for Q3 2025.

  • On a quarterly basis, Times Interest Earned rose 98.98% to -$42.14 in Q3 2025 year-over-year; TTM through Sep 2025 was -$118.87, a 98.94% increase, with the full-year FY2024 number at -$11463.6, down 318.25% from a year prior.
  • Times Interest Earned was -$42.14 for Q3 2025 at Altimmune, up from -$86.83 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $388.34 in Q4 2021 to a low of -$26794.0 in Q1 2024.
  • A 5-year average of -$7674.3 and a median of -$1118.7 in 2021 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: skyrocketed 107.06% in 2021, then tumbled 13421.66% in 2023.
  • Altimmune's Times Interest Earned stood at $388.34 in 2021, then crashed by 67.5% to $126.2 in 2022, then tumbled by 13421.66% to -$16811.5 in 2023, then crashed by 47.91% to -$24866.0 in 2024, then skyrocketed by 99.83% to -$42.14 in 2025.
  • Per Business Quant, the three most recent readings for ALT's Times Interest Earned are -$42.14 (Q3 2025), -$86.83 (Q2 2025), and -$21815.0 (Q1 2025).